Fundraising Fox
/People
Sign in

George Golumbeski

Investor

Partner at Droia Ventures · Board director at Judo Bio

London, England, United Kingdom

Find your path to George

154 people in our graph can introduce you to George.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Matthias Van Woensel to introduce you to George

You →Matthias · together at Droia Ventures (2020–2026) →George

Ask Jamie Chen to introduce you to George

You →Jamie · 8 people · together at Droia Ventures →George

Ask Sam Okafor to introduce you to George

You →Sam · 3 people · together at Elan Pharmaceuticals →George

Sign up to find every way you can get introduced to George

  • Your email: the people you already email who know George
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with George
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Partner with a PhD in genetics from University of Wisconsin-Madison. Former executive at Novartis and Celgene (Bristol Myers Squibb) and at Arch Venture Partners; board member of Acceleron Pharma, Sage Therapeutics, Carrick Therapeutics and Shattuck Labs.

Contact· self-published, not guessed

Board director at Judo Bio

Intro paths

→

In turn, George can intro founders to Judo Bio's investors below.

Judo Bio's investors · 5

Atlas VentureCambridge · $500K – $1M checks · since 2024Digitalis VenturesNew York · $100K – $10M checks · since 2024Droia VenturesLuxembourg · $540K checksThe Column GroupSan Francisco · $30M checks · since 2023YK BioventuresBurlingame

Co-founders at Judo Bio

AFAndrew Fraley
Andrew FraleyCo-founder
ASAlfica Sehgal
Alfica Sehgal

Experience

  1. DROIA VenturesPartner at DROIA VENTUREScurrent2020 — presentGreater NYC Area
  2. Independent ConsultantIndependent Biotechnology Executivecurrent2018 — presentGreater New York City Area
  3. CelgeneExecutive Vice President Business Development2009 — 2018Greater New York City Area
  4. NovartisVice President Business Development, Licensing, and Strategy2002 — 2008
  5. Elan PharmaceuticalsVice President - R&D Business Development2001 — 2002
  6. Schwarz PharmaVice President of Corporate Development1997 — 2000

Skills & more

Pharmaceutical Industry99Clinical Development54Biotechnology99Divestitures20Lifesciences43Oncology88Infection9Biomarkers1Business Development21Biopharmaceuticals28Business Strategy9CRO6
+12 moreCTMSCardiologyClinical TrialsCommercializationCorporate DevelopmentDermatologyDiabetesDrug DevelopmentLeadershipManagementStrategyFDA

From George's professional profile.

Colleagues at Droia Ventures

Alexander Depauw
Head of Legal at Droia Ventures
Dan Nomura
Investment Advisory Board at Droia Ventures
Dieter Petit
Senior Associate at Droia Ventures
Diether Lambrechts
Investment Advisory Board at Droia Ventures
Eric Rowinsky
Investment Advisory Board at Droia Ventures
Evelien Verdrengh
Office Manager & Executive Assistant at Droia Ventures
Guy Eelen
VP R&D – Droia Labs at Droia Ventures
Hendrik P.N. Scholl
Investment Advisory Board at Droia Ventures

Frequently asked questions

Who is George Golumbeski?
Partner with a PhD in genetics from University of Wisconsin-Madison. Former executive at Novartis and Celgene (Bristol Myers Squibb) and at Arch Venture Partners; board member of Acceleron Pharma, Sage Therapeutics, Carrick Therapeutics and Shattuck Labs.
Where does George Golumbeski work?
George Golumbeski is Partner at Droia Ventures and Board director at Judo Bio.
Where did George Golumbeski go to school?
George Golumbeski studied at University of Wisconsin-Madison (PhD, Genetics / Molecular Biology); University of Virginia (BA, Biology).

Same school

Shared employers